Document is current

Article History

Accepted: 29 May 2025

First Online: 23 June 2025

Declarations

:

: Open access funding provided by University of Pécs. Antal T. Zemplenyi authored this article during his Fulbright Visiting Scholarship at the University of Colorado Anschutz Medical Campus.

: Antal T. Zemplenyi, Nai-Chia Chen, Kelly E. Anderson, Blythe Adamson, Michael J. DiStefano, Kavita V. Nair, and Robert B. McQueen have disclosed no conflicts of interest concerning the research, authorship, or publication of this article. None of the authors is affiliated with or holds financial interests in the manufacturers of the drugs investigated in this study. The views expressed in this article represent the opinions of the authors and do not necessarily reflect those of their respective employers.

: The study was declared exempt by the Colorado Multiple Institutional Review Board (23-1001).

: Not applicable.

: Not applicable.

: The data that support the findings of this study were originated by and are the property of Flatiron Health, Inc., which has restrictions prohibiting the authors from making the data set publicly available. Requests for data sharing by license or by permission for the specific purpose of replicating results in this article can be submitted to PublicationsDataAccess@flatiron.com.

: Not applicable.

: AZ, BM, MD, KA, BA, and KN contributed to the study conception and design. Material preparation, data collection, and analysis were performed by N-CC and AZ. The first draft of the manuscript was written by AZ and BM and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.